Pine Harbor Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Hold
1,515
0.42% 26
2025
Q4
$1.63M Buy
1,515
+17
+1% +$16.3K 0.5% 24
2025
Q3
$1.14M Buy
1,498
+17
+1% +$12.7K 0.37% 34
2025
Q2
$1.15M Hold
1,481
0.41% 33
2025
Q1
$1.22M Buy
1,481
+2
+0.1% +$1.66K 0.49% 29
2024
Q4
$1.14M Buy
1,479
+2
+0.1% +$1.66K 0.46% 32
2024
Q3
$1.31M Hold
1,477
0.65% 29
2024
Q2
$1.34M Buy
1,477
+2
+0.1% +$1.6K 0.79% 29
2024
Q1
$1.15M Buy
1,475
+1
+0.1% +$712 0.72% 30
2023
Q4
$859K Buy
+1,474
New +$860K 0.65% 31

Other funds holding LLY

Pine Harbor Wealth Management's LLY Position: Q1 2026 in Review

Pine Harbor Wealth Management held its Eli Lilly (LLY) position steady in Q1 2026 at 1,515 shares worth $1.39M. The position accounts for 0.42% of the portfolio, ranked #26.

Pine Harbor Wealth Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.63M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pine Harbor Wealth Management held 1,515 shares of Eli Lilly worth $1.39M as of Q1 2026.
  • Pine Harbor Wealth Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.42% of Pine Harbor Wealth Management's portfolio in Q1 2026, its #26 holding.
  • Pine Harbor Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Pine Harbor Wealth Management's Eli Lilly position peaked at $1.63M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pine Harbor Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.